Avita Medical | 1811094D - Capitalisation Boursière





Capitalisation Boursière Changement Date
Celltrion KRW 37.87T 35.44T 2026-07
Clinuvel Pharmaceuticals AUD 625.5M 105.22M 2025-12
Cochlear AUD 17.05B 2.6B 2025-12
CSL USD 55.89B 20.42B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 2.71B 1.87B 2026-07
Divis Laboratories Ltd INR 1.58T 118.27B 2026-03
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Mayne Pharma AUD 252.67M 153.55M 2025-12
Medical Developments International AUD 62.53M 563.29K 2025-12
Nanosonics AUD 1.2B 25.43M 2025-12
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 136.51M 115.96M 2026-07
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pacific Edge NZD 177.94M 16.27M 2026-06
Paradigm Biopharmaceuticals AUD 145.7M 26.92M 2025-12
Pharma Mar EUR 1.57B 225M 2026-03
Polynovo AUD 849.74M 24.18M 2025-12
PYC Therapeutics AUD 965.3M 209.97M 2025-12
Qiagen NV USD 8.02B 256M 2026-07
Ramsay Health Care AUD 7.93B 537.83M 2025-12
ResMed USD 29.75B 17.81B 2026-07
Sartorius EUR 7.63B 8B 2026-07
Telix Pharmaceuticals AUD 5.07B 5.81B 2025-12
Zealand Pharma A/S 33.35B 448.34M 2025-12